Clinical Efficacy and Safety of Intravenous Tissue Plasminogen Activator in Acute Embolic Stroke: A Randomized, Double-Blind, Dose-Comparison Study of Duteplase
Authors:
- for the Japanese Thrombolysis Study GroupFGfor the Japanese Thrombolysis Study Group
- 1 January 1995
- book chapter
- Published by Springer Nature
- p. 223-229
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic StrokeCerebrovascular Diseases, 1993
- Intravenous Tissue Plasminogen Activator in Acute Thromboembolic Stroke: A Placebo-Controlled, Double-Blind Trial1993
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992
- Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.Stroke, 1992
- Intravenous recombinant tissue plasminogen activator in acute carotid artery territory strokeNeurology, 1992
- 'Spectacular shrinking deficit'Neurology, 1992
- Thrombolytic Therapy in Embolic and Thrombotic Cerebral Infarction: A Cooperative Study1991
- Graded neurologic scale for use in acute hemispheric stroke treatment protocols.Stroke, 1987